Korea vs Malawi: Treatment success rate for patients treated for MDR-TB
Korea
74.0%
in 2022
Malawi
74.0%
in 2022
Korea rank
78th
Malawi rank
78th
Treatment success rate for patients treated for MDR-TB over time
- Korea
- Malawi
How they compare
Korea currently reports 74.0% against 74.0% in Malawi, a difference of 0.0%.
The two have swapped places 4 times across 12 shared years of data; in 2011 it was Malawi ahead.
Korea ranks 78th and Malawi ranks 78th of 163 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.4% | 62.8% | 3.7% | Korea |
| 2020s | 75.7% | 72.0% | 3.7% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Korea or Malawi?
- Korea, at 74.0% against 74.0% in Malawi as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Korea and Malawi?
- 0.0%, with Korea ahead.
- How many years of comparable data are there for Korea and Malawi?
- 12 years are reported by both, from 2011 to 2022.
- How do Korea and Malawi rank globally for treatment success rate for patients treated for mdr-tb?
- Korea ranks 78th and Malawi ranks 78th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.